First Mercantile Trust Co. Takes Position in Anthem Inc (NYSE:ANTM)

First Mercantile Trust Co. purchased a new stake in shares of Anthem Inc (NYSE:ANTM) during the third quarter, Holdings Channel reports. The institutional investor purchased 420 shares of the company’s stock, valued at approximately $101,000.

Several other hedge funds have also modified their holdings of the company. Asymmetry Capital Management L.P. purchased a new position in Anthem in the second quarter valued at about $4,679,000. Evolution Wealth Advisors LLC purchased a new position in Anthem in the second quarter valued at about $55,000. Integre Asset Management LLC purchased a new position in Anthem in the second quarter valued at about $2,182,000. First Citizens Bank & Trust Co. grew its stake in Anthem by 4.6% in the second quarter. First Citizens Bank & Trust Co. now owns 17,650 shares of the company’s stock valued at $4,981,000 after purchasing an additional 771 shares in the last quarter. Finally, Lederer & Associates Investment Counsel CA grew its stake in Anthem by 3.9% in the third quarter. Lederer & Associates Investment Counsel CA now owns 5,495 shares of the company’s stock valued at $1,319,000 after purchasing an additional 205 shares in the last quarter. Institutional investors and hedge funds own 89.09% of the company’s stock.

In related news, EVP Peter D. Haytaian sold 9,586 shares of the business’s stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $269.57, for a total transaction of $2,584,098.02. Following the completion of the transaction, the executive vice president now owns 42,488 shares of the company’s stock, valued at approximately $11,453,490.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.17% of the stock is currently owned by insiders.

Shares of NYSE:ANTM traded up $5.22 on Tuesday, reaching $284.37. The company had a trading volume of 431,131 shares, compared to its average volume of 1,714,334. Anthem Inc has a twelve month low of $227.16 and a twelve month high of $317.99. The stock has a 50-day moving average price of $254.03 and a 200 day moving average price of $270.83. The stock has a market capitalization of $71.53 billion, a P/E ratio of 17.90, a P/E/G ratio of 1.04 and a beta of 0.74. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 0.60.

Anthem (NYSE:ANTM) last announced its quarterly earnings results on Wednesday, October 23rd. The company reported $4.87 earnings per share for the quarter, topping analysts’ consensus estimates of $4.82 by $0.05. Anthem had a return on equity of 15.59% and a net margin of 4.29%. The company had revenue of $26.44 billion during the quarter, compared to analysts’ expectations of $25.88 billion. During the same quarter in the previous year, the firm earned $3.81 earnings per share. The business’s quarterly revenue was up 15.1% compared to the same quarter last year. On average, sell-side analysts predict that Anthem Inc will post 19.43 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Thursday, December 5th will be given a dividend of $0.80 per share. The ex-dividend date is Wednesday, December 4th. This represents a $3.20 annualized dividend and a dividend yield of 1.13%. Anthem’s dividend payout ratio is presently 20.14%.

A number of research analysts have commented on ANTM shares. Mizuho started coverage on Anthem in a research note on Thursday, October 17th. They issued a “neutral” rating and a $262.00 target price on the stock. Deutsche Bank started coverage on Anthem in a research note on Thursday, September 12th. They issued a “buy” rating on the stock. Credit Suisse Group lowered their target price on Anthem from $345.00 to $340.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. Zacks Investment Research downgraded Anthem from a “buy” rating to a “hold” rating and set a $289.00 target price on the stock. in a research note on Monday, August 19th. Finally, Morgan Stanley boosted their target price on Anthem from $356.00 to $360.00 and gave the company an “overweight” rating in a research note on Thursday, October 24th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and thirteen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $319.72.

About Anthem

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.

Featured Story: Futures Contract

Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem Inc (NYSE:ANTM).

Institutional Ownership by Quarter for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.